India Morning Call - Global Markets - Reuters India
Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For … - Forbes
VANCOUVER and DEERFIELD, IL, Aug. 11 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) and its co-development partner Astellas Pharma US, Inc. (”Astellas”) today announced that they have received an action letter dated August 8 …